MARIKO LYTELL

• US Equities Day Trader specializing in momentum trading with a strong foundation in technical analysis and disciplined risk management.
• Skilled in executing high-probability setups and maintaining strict adherence to risk management frameworks, ensuring consistent performance and account growth.

• Led B2B and growth strategy for APAC, driving market expansion and new product development initiatives.
• Secured $200M in partnership agreements with key distributors across the region, contributing to sustained revenue growth.
• Oversaw four satellite offices in Southeast Asia (Malaysia, Philippines, Thailand, and Vietnam), fostering local team alignment with corporate objectives.
• Directed end-to-end commercial operations, from partner identification and regulatory approval coordination to commercial launch strategies for each individual market.

Executed over 65 consulting engagements, delivering strategic solutions across portfolio prioritization, market entry, and corporate strategy:

• Portfolio Prioritization & Partnership Development for a cell therapy company: Conducted comprehensive asset prioritization based on market size, competitive landscape, pricing potential, and reimbursement dynamics; identified and facilitated potential development and commercial partnerships.
• Corporate Strategy for a digital pharmacy: Led a strategy workshop to integrate recent acquisitions into a cohesive business unit, creating a roadmap focused on patient engagement, organic growth, and future acquisitions.
• Market Entry Strategy for a Korean biopharma: Designed a U.S. commercial launch strategy for a CNS therapy, emphasizing sales, payer engagement, and physician advocacy to drive market penetration.